The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial.
 
Joohyuk Sohn
Stock and Other Ownership Interests - Daiichi Sankyo (I)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myerss guibb (Inst); Celcuity (Inst); Daiichi Sankyo (Inst); Dragonfly Therapeutics (Inst); Eikon (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hanmi Pharm (Inst); HLB Life Science (Inst); ILDONG PHARMACEUTICAL (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Olema Oncology (Inst); Pfizer (Inst); Qurient (Inst); Roche (Inst); Samyang Holdings (Inst); Sanofi (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
 
Seungtaek Lim
No Relationships to Disclose
 
Jae Ho Jeong
No Relationships to Disclose
 
Kyung-Hun Lee
Honoraria - Daiichi Sankyo; Novartis; Pfizer; Roche
 
Keun Seok Lee
Consulting or Advisory Role - Bixink; Everest Pharmaceutical; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Dong-A ST (Inst); Novartis (Inst)
 
Yong Wha Moon
No Relationships to Disclose
 
Ji-Yeon Kim
No Relationships to Disclose
 
Jieun Lee
No Relationships to Disclose
 
Hee Jun Kim
No Relationships to Disclose
 
Yee Soo Chae
No Relationships to Disclose
 
Jee Hung Kim
No Relationships to Disclose
 
Suee Lee
No Relationships to Disclose
 
In Hae Park
Research Funding - Roche
 
Seok Yun Kang
No Relationships to Disclose
 
KyongHwa Park
Stock and Other Ownership Interests - iMBDx
Honoraria - Celltrion
Consulting or Advisory Role - AstraZeneca; Daichi Sankyo
Patents, Royalties, Other Intellectual Property - IP transfer fee
Expert Testimony - LegoChem Biosciences
 
Eun Kyung Cho
No Relationships to Disclose
 
Han Jo Kim
No Relationships to Disclose
 
Gun Min Kim
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai
 
Min Hwan Kim
Stock and Other Ownership Interests - AIMA company
Honoraria - AstraZeneca; Boryung Pharmaceuticals; Boryung Pharmaceuticals; Celltrion; Celltrion; Daiichi Sankyo; Eisai; MSD
Consulting or Advisory Role - Boryung Pharmaceuticals; Daiichi Sankyo; Eisai
Research Funding - AstraZeneca; Boryung Pharmaceuticals; Celltrion; Daewoong Pharmaceutical
 
Kyoo Hyun Kim
No Relationships to Disclose